HeartSciences Inc Warrant
HSCSW
2 hedge funds and large institutions have $109K invested in HeartSciences Inc Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
4.8% more ownership
Funds ownership: 0% → 4.8% (+4.8%)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Clear Street
New York
|
+$23.8K |
Top Sellers
HSCSW Hedge Fund Activity: Q3 2022 in Review
2 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q3 2022, worth a combined $109K — down 38% from $176K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HSCSW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Clear Street, adding an estimated $23.8K.
- 2 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q3 2022, down from 3 in Q2 2022.
- Funds reported $109K of HeartSciences Inc Warrant stock for Q3 2022, down 38% quarter-over-quarter.
- 0 funds opened new HeartSciences Inc Warrant positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest HeartSciences Inc Warrant buyer in Q3 2022 was Clear Street, an estimated $23.8K added.
Based on aggregated 13F filings for Q3 2022.